New Research Supports Safety of Aspirin in Heart Failure

Share this content:
New Research Supports Safety of Aspirin in Heart Failure
New Research Supports Safety of Aspirin in Heart Failure

TUESDAY, Aug. 1, 2017 (HealthDay News) -- Some research has raised concerns about the safety of aspirin for heart failure patients, but a new study, published in the Aug. 1 issue of JACC: Heart Failure, appears to offer some reassurance.

Shunichi Homma, M.D., from the New York-Presbyterian/Columbia University Medical Center in New York City, and colleagues analyzed data from a clinical trial in which heart failure patients were randomly assigned to take either aspirin or warfarin. Patients in the aspirin group took 325 mg per day.

The study, of 2,305 patients, found that those on daily aspirin were not at heightened risk of being hospitalized for, or dying from, heart failure. Over 10 years, 19.3 percent of aspirin patients were hospitalized for heart failure, or died of the disease. That compared with 23.2 percent of warfarin users. Homma's team also accounted for other factors, including patients' age and heart disease severity. In the end, there was no statistical difference between the two groups in their risk of heart failure complications.

"Among patients with heart failure with reduced ejection fraction in the WARCEF [Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction] trial, there was no significant difference in risk of heart failure events between the aspirin and warfarin-treated patients," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »